Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: Niamh O'Connell
5
Mins
April 2024
When I was a medical student in the small university city of Cork, in Ireland, there was one female consultant, and she was a haematologist…
Read more
10
Mins
22nd March 2022
Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy
The hypomethylating agents (HMA), azacitidine and decitabine, are currently regarded as the standard of care for patients with…
13
Mins
18th March 2022
The Future of Gene Therapy for Haemophilia A and B: Innovative Treatment Management Strategies, Perspectives, and Updated Trial Results
Monogenic diseases such as haemophilia A and B are inherited conditions arising from mutations in a single gene. One defective gene leads…
9
Mins
21st February 2022
The Search for Sustained Durability in Higher-Risk Myelodysplastic Syndrome: New Treatment Pathways in Sight
Higher-risk MDS is a collective term based on the Revised International Prognostic Scoring System (IPSS-R) that encompasses…
4
Mins
3rd February 2022
Digital Necrosis in Multiple Myeloma
Multiple myeloma (MM) is a B cell malignancy characterised by abnormal proliferation of plasma cells that expand in the bone marrow…
12
Mins
31st January 2022
Updates on Isatuximab in Relapsed/Refractory and Newly Diagnosed Multiple Myeloma
In the past decade, therapies that are more effective and less toxic have transformed the treatment landscape for patients with MM…
6
Mins
24th January 2022
Atorvastatin, Aspirin, and Hydroxyurea Treating Polycythaemia Vera
The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…
9
Mins
15th December 2021
Optimising Outcomes in Cutaneous T Cell Lymphoma: Role of Blood Involvement and Treatment Options
CTCL is a rare type of non-Hodgkin lymphoma, primarily presenting in the skin but with extracutaneous involvement in some patients. Around…
14
Mins
13th December 2021
Genome Editing and CAR-T Cell Therapy
Recent efforts to incorporate genome editing into CAR T cell therapy offers novel opportunities for treatment of haematologic malignancies…
Loading posts...
« Previous
1
2
3
4
5
6
…
21
Next »